A detailed history of Wells Fargo & Company transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 64,970 shares of IRWD stock, worth $273,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,970
Previous 63,617 2.13%
Holding current value
$273,523
Previous $414,000 35.51%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.93 - $7.04 $5,317 - $9,525
1,353 Added 2.13%
64,970 $267,000
Q2 2024

Aug 13, 2024

BUY
$5.58 - $8.61 $68,784 - $106,135
12,327 Added 24.03%
63,617 $414,000
Q1 2024

May 10, 2024

BUY
$8.32 - $15.45 $57,075 - $105,987
6,860 Added 15.44%
51,290 $446,000
Q4 2023

Feb 09, 2024

SELL
$8.79 - $11.51 $1.32 Million - $1.73 Million
-150,708 Reduced 77.23%
44,430 $508,000
Q3 2023

Nov 13, 2023

BUY
$8.25 - $11.35 $38,040 - $52,334
4,611 Added 2.42%
195,138 $1.88 Million
Q2 2023

Aug 15, 2023

BUY
$10.1 - $11.6 $485,577 - $557,693
48,077 Added 33.75%
190,527 $2.03 Million
Q1 2023

May 12, 2023

BUY
$10.37 - $12.56 $493,103 - $597,240
47,551 Added 50.11%
142,450 $1.5 Million
Q4 2022

Feb 13, 2023

SELL
$9.9 - $12.43 $73,636 - $92,454
-7,438 Reduced 7.27%
94,899 $1.18 Million
Q3 2022

Nov 14, 2022

SELL
$10.14 - $12.38 $1.44 Million - $1.75 Million
-141,530 Reduced 58.04%
102,337 $1.06 Million
Q2 2022

Aug 12, 2022

SELL
$11.05 - $12.72 $3.37 Million - $3.88 Million
-304,914 Reduced 55.56%
243,867 $2.81 Million
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $460,675 - $559,236
-43,419 Reduced 7.33%
548,781 $6.9 Million
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $7.65 Million - $9.83 Million
-704,839 Reduced 54.34%
592,200 $6.91 Million
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $4.01 Million - $4.68 Million
336,513 Added 35.03%
1,297,039 $16.9 Million
Q2 2021

Aug 16, 2021

BUY
$10.16 - $13.11 $4.14 Million - $5.35 Million
407,825 Added 73.79%
960,526 $12.4 Million
Q1 2021

May 13, 2021

BUY
$9.04 - $11.86 $1.33 Million - $1.75 Million
147,556 Added 36.42%
552,701 $6.18 Million
Q4 2020

Feb 09, 2021

SELL
$9.05 - $12.2 $285,337 - $384,653
-31,529 Reduced 7.22%
405,145 $4.62 Million
Q3 2020

Nov 05, 2020

SELL
$8.99 - $10.74 $83,544 - $99,806
-9,293 Reduced 2.08%
436,674 $3.93 Million
Q2 2020

Aug 13, 2020

BUY
$9.14 - $11.97 $1.04 Million - $1.36 Million
113,364 Added 34.08%
445,967 $4.6 Million
Q1 2020

May 14, 2020

BUY
$8.58 - $14.01 $2.85 Million - $4.66 Million
332,603 New
332,603 $3.36 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $645M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.